Patent Applications published on Apr 17, 2025 - page 3

#601
US20250120930A1
Human necessities

COMPOSITIONS CONTAINING DOFETILIDE AND MEXILETINE AND USES THEREOF

#602
US20250120931A1
Human necessities

TREATMENT OF MULTIPLE SCHLEROSIS COMPRISING DHODH INHIBITORS

#603
US20250120932A1
Human necessities

PHARMACEUTICAL COMPOSITION

#604
US20250120933A1
Human necessities

AGENT FOR INHIBITING RENAL DAMAGE INDUCED BY RHABDOMYOLYSIS

#605
US20250120934A1
Human necessities

COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF

#606
US20250120935A1
Human necessities

COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF

#607
US20250120936A1
Human necessities

COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF

#608
US20250120937A1
Human necessities

THERAPEUTICS AND METHOD FOR TREATING OSTEOARTHRITIS

#609
US20250120938A1
Human necessities

ENANTIOMERS OF A2-73, ANALOGUES, AND SIGMA AGONIST ACTIVITY

#610
US20250120939A1
Human necessities

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

#611
US20250120940A1
Human necessities

COMPOSITION FOR IMPROVING FATIGUE, EXERCISE PERFORMANCE, OR ENDURANCE COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN

#612
US20250120941A1
Human necessities

Composition for Promoting the Assimilation of an Oligosaccharide

#613
US20250120942A1
Human necessities

BRAIN FUNCTION IMPROVING AGENT

#614
US20250120943A1
Human necessities

RIFAMYCIN OPHTHALMIC COMPOSITION AND USE THEREOF

#615
US20250120944A1
Human necessities

ANTIBACTERIAL COMPOSITION

#616 ✅ Patent 12,370,174 granted on 2025-07-29
US20250120945A1
Human necessities

METHODS OF IMPROVING RENAL FUNCTION

#617
US20250120946A1
Human necessities

USE OF PYRROLE COMPOUND IN TREATMENT OF TUMORS

#618
US20250120947A1
Human necessities

COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO CISPLATIN

#619
US20250120948A1
Human necessities

Small Molecules G(alpha)I2 Inhibitors and Combination With Anticancer Drugs and Use Thereof

#620
US20250120949A1
Human necessities

USE OF SPLA2 INHIBITORS TO TREAT ENVENOMATION BY SNAKES AND WASPS

#621
US20250120950A1
Human necessities

USE OF SPLA2 INHIBITORS TO TREAT HYMENOPTERA ENVENOMATION, HEMOLYSIS, AND KIDNEY DISEASE, AND TO PROTECT BLOOD FROM OSMOTIC FRAGILITY

#622
US20250120951A1
Human necessities

CLEMIZOLE FORMULATION

#623
US20250120952A1
Human necessities

17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors And Methods Of Use Thereof

#624
US20250120953A1
Human necessities

COMBINATIONS OF BETA-LACTAM COMPOUNDS, PROBENECID, AND VALPROIC ACID AND USES THEREOF

#625
US20250120954A1
Human necessities

TREATMENT OF RESTENOSIS USING TEMSIROLIMUS

#626
US20250120955A1
Human necessities

TACROLIMUS FOR IMPROVED TREATMENT OF TRANSPLANT PATIENTS

#627
US20250120956A1
Human necessities

Azole Compounds for Enhancing Telomerase Reverse Transcriptase (TERT) Expression

#628
US20250120957A1
Human necessities

TREATMENT OF NEUROPSYCHIATRIC DISORDERS WITH TILIVAPRAM

#629
US20250120958A1
Human necessities

Treatment of GM2 Gangliosidosis

#630
US20250120959A1
Human necessities

NEW FORMULATIONS OF PITOLISANT AND METHODS OF USE

#631
US20250120960A1
Human necessities

Compositions and Methods for Treatment of Inflammatory Bowel Disease

#632
US20250120961A1
Human necessities

P53 MODULATORS

#633
US20250120962A1
Human necessities

NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME

#634
US20250120963A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF THROMBOCYTOPENIA

#635
US20250120964A1
Human necessities

USE OF NOVEL MOLECULAR GLUE

#636
US20250120965A1
Human necessities

METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION

#637
US20250120966A1
Human necessities

ANTI-AGEING SUPPLEMENT

#638
US20250120967A1
Human necessities

TYROSINE KINASES INHIBITORS AND USES THEREOF

#639
US20250120968A1
Human necessities

METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS

#640
US20250120969A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION INJURY IN THE LUNGS

#641
US20250120970A1
Human necessities

PHARMACEUTICAL COMPOSITION INCLUDING PHTHALAZINONE DERIVATIVE FOR CO-ADMINISTRATION WITH ANTICANCER DRUG

#642
US20250120971A1
Human necessities

NOVEL DRUG TREATMENT OF COGNITIVE IMPAIRMENTS ASSOCIATED WITH SCHIZOPHRENIA

#643
US20250120972A1
Human necessities

PHARMACY COMPOUNDED PRESCRIPTION COMPOSITIONS FOR HAIR GROWTH

#644
US20250120973A1
Human necessities

COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

#645
US20250120974A1
Human necessities

PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE

#646
US20250120975A1
Human necessities

INTEGRIN INHIBITORS FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS

#647
US20250120976A1
Human necessities

BIOMARKERS OF METHOTREXATE-INDUCED IMMUNE TOLERANCE

#648
US20250120977A1
Human necessities

METHODS OF TREATING PATIENTS SUFFERING FROM BRAIN INJURY AND METHODS OF INCREASING THE VALUE OF THE EXTENDED GLASGOW OUTCOME SCALE OF PATIENTS SUFFERING FROM BRAIN INJURY

#649
US20250120978A1
Human necessities

JAK INHIBITOR WITH ERK1/2 AND/OR SHP2 INHIBITORS COMBINATION THERAPY

#650 ✅ Patent 12,343,348 granted on 2025-07-01
US20250120979A1
Human necessities

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME

#651
US20250120980A1
Human necessities

DIBENZODIAZEPINE COMPOUNDS AND USE IN INTERFERON ACTIVATOR PROTEIN AGONISTS THEREOF

#652
US20250120981A1
Human necessities

MRTX1133 PHARMACEUTICAL COMPOSITIONS

#653
US20250120982A1
Human necessities

COVALENT TARGETING OF E3 LIGASES

#654
US20250120983A1
Human necessities

PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME

#655
US20250120984A1
Human necessities

PREDNISONE ENTERIC-COATED PREPARATION AND PREPARATION METHOD THEREOF

#656
US20250120985A1
Human necessities

METHOD OF TREATING DIABETIC MACULAR EDEMA

#657
US20250120986A1
Human necessities

STEROL THERAPY

#658
US20250120987A1
Human necessities

METHOD FOR TREATING CANCER USING HUMAN MITOCHONDRIAL MALIC ENZYME 2 INHIBITOR

#659
US20250120988A1
Human necessities

SMALL MOLECULE COMPOUND FOR TREATING ISCHEMIC STROKE, ITS PREPARATION METHOD, AND APPLICATION

#660
US20250120989A1
Human necessities

BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF

#661
US20250120990A1
Human necessities

METHOD AND COMPOSITION FOR TREATING PARASITES IN AN ANIMAL

#662
US20250120991A1
Human necessities

TOPICAL ANALGESIC

#663
US20250120992A1
Human necessities

COMPOSITION FOR IMPROVING LIVER HEALTH COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN

#664
US20250120993A1
Human necessities

COMPOSITION FOR CONTROLLING BLOOD SUGAR COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN

#665
US20250120994A1
Human necessities

AZITHROMYCIN AND ROXITHROMYCIN DERIVATIVES AS SENOLYTIC DRUGS

#666
US20250120995A1
Human necessities

USE OF MARIBAVIR IN TREATMENT REGIMENS

#667
US20250120996A1
Human necessities

T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

#668
US20250120997A1
Human necessities

INTRASPINAL DELIVERY OF THERAPEUTIC AGENTS

#669
US20250120998A1
Human necessities

REPAIR OF ENDOTHELIAL GLYCOCALYX

#670
US20250120999A1
Human necessities

SYSTEMS AND METHODS USING SULFATED GLYCOSAMINOGLYCANS (GAGs) AND GAG ANALOGS TO TREAT OR PREVENT MONKEYPOX (MPOX)

#671
US20250121000A1
Human necessities

INHALABLE BICARBONATE COMPOSITIONS AND DELIVERY SYSTEMS THEREFOR

#672
US20250121001A1
Human necessities

METHOD FOR ENHANCING EMBRYO IMPLANTATION

#673
US20250121002A1
Human necessities

ANTI-EGFRviii ANTIBODY, POLYPEPTIDE, CELL CAPABLE OF EXPRESSING SAID POLYPEPTIDE, PHARMACEUTICAL COMPOSITION COMPRISING SAID CELL, METHOD FOR PRODUCING SAID CELL, AND POLYNUCLEOTIDE OR VECTOR COMPRISING NUCLEOTIDE SEQUENCE ENCODING SAID POLYPEPTIDE

#674
US20250121003A1
Human necessities

DEVELOPING INDUCIBLE CLUSTER CHIMERIC ANTIGEN RECEPTOR (CCAR) CONSTRUCTS

#675
US20250121004A1
Human necessities

COMPOSITIONS AND METHODS COMPRISING ANTI-CD38 CHIMERIC ANTIGEN RECEPTORS (CARS)

#676
US20250121005A1
Human necessities

CAR and Polyspecific Binding Molecules Targeting Solid Tumors

#677
US20250121006A1
Human necessities

THERAPEUTIC COMBINATIONS COMPRISING ANTI-STEAP2 CHIMERIC ANTIGEN RECEPTOR T CELLS

#678
US20250121007A1
Human necessities

COMPOSITIONS FOR THE TREATMENT OF CANCER

#679
US20250121008A1
Human necessities

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

#680
US20250121009A1
Human necessities

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

#681
US20250121010A1
Human necessities

A BIOMARKER INDICATING THE THERAPEUTIC EFFICACY OF EXTRACELLULAR VESICLE (EV)- PREPARATIONS

#682
US20250121011A1
Human necessities

LIQUID PROBIOTIC COMPOSITION FOR GREATER TOLERANCE TO HEAT STRESS IN POULTRY, METHOD OF PRODUCING THE COMPOSITION AND USE THEREOF IN THE TREATMENT OF POULTRY

#683
US20250121012A1
Human necessities

ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT

#684
US20250121013A1
Human necessities

USE OF BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING PARKINSON'S DISEASE

#685
US20250121014A1
Human necessities

METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING BUTYRATE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF

#686
US20250121015A1
Human necessities

USE OF LACTOBACILLUS PLANTARUM STRAIN, ITS METABOLITE, OR COMPOSITION CONTAINING THE SAME STRAIN FOR REPAIRING OR PREVENTING RETINAL DAMAGE

#687
US20250121016A1
Human necessities

SWINE ORIGIN PROBIOTICS THAT PROMOTE HEALTH AND GROWTH PERFORMANCE IN PIGS

#688
US20250121017A1
Human necessities

ONCOLYTIC VIROTHERAPY COMPOSITIONS AND METHODS

#689
US20250121018A1
Human necessities

SUNFLOWER SEED COMPOSITION RICH IN PLEASANT PROHORMONE AND ANTI-DEPRESSION APPLICATION THEREOF

#690
US20250121019A1
Human necessities

METHODS AND SYSTEMS FOR MAKING OIL-LOADED POWDERS AND USE THEREOF

#691
US20250121020A1
Human necessities

COMPOSITION FOR IMPROVING MEMORY AND PREVENTING, ALLEVIATING, OR TREATING COGNITIVE DISORDER COMPRISING YUKGUNJATANG AS EFFECTIVE COMPONENT

#692
US20250121021A1
Human necessities

PREPARATION METHOD, USE, AND QUALITY DETECTION METHOD OF PANAX NOTOGINSENG-BLETILLA STRIATA ORAL LIQUID

#693
US20250121022A1
Human necessities

ALPINIAE OFFICINARUM RHIZOME EXTRACT, PREPARATION METHOD AND USE THEREOF

#694
US20250121023A1
Human necessities

COMPOSITION FOR PREVENTING, IMPROVING, OR ALLEVIATING SYMPTOMS RELATING TO QI DEFICIENCY AND/OR BLOOD DEFICIENCY

#695
US20250121024A1
Human necessities

COMBINED USE OF IMIQUIMOD AND A CASEIN HYDROLYSATE FOR THE TREATMENT OF CONDYLOMA

#696
US20250121025A1
Human necessities

SCALP-DERIVED PEPTIDES ALLEVIATING HAIR LOSS SYMPTOMS

#697
US20250121026A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING FIBROSIS

#698
US20250121027A1
Human necessities

COMPOSITIONS AND USES OF ANTIMICROBIAL MATERIALS WITH TISSUE-COMPATIBLE PROPERTIES

#699
US20250121028A1
Human necessities

USE OF LINK-TSG6 FOR THE TREATMENT OF OSTEOARTHRITIC PAIN

#700
US20250121029A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL AND OTHER DISORDERS

#701
US20250121030A1
Human necessities

High Concentration VEGF Receptor Fusion Protein Containing Formulations

#702
US20250121031A1
Human necessities

EGF-RICH EXOSOMES, PREPARATION METHOD AND USE THEREOF

#703
US20250121032A1
Human necessities

METHODS OF TREATING CHEMOTHERAPY INDUCED NEUTROPENIA USING FIXED DOSES OF G-CSF PROTEIN COMPLEX

#704
US20250121033A1
Human necessities

PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS

#705
US20250121034A1
Human necessities

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

#706
US20250121035A1
Human necessities

CONTROLLED RELEASE PEPTIDE FORMULATIONS

#707
US20250121036A1
Human necessities

METHODS OF TREATING HEMOPHILIC ARTHROPATHY USING CHIMERIC CLOTTING FACTORS

#708
US20250121037A1
Human necessities

INERT MATRICES FOR QUALITATIVE AND SEMI-QUANTITATIVE SEED AMPLIFICATION ASSAYS

#709
US20250121038A1
Human necessities

NUCLEIC ACID ENCODING RRM2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE TO RESIST DEGRADATION

#710
US20250121039A1
Human necessities

TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES

#711
US20250121040A1
Human necessities

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

#712
US20250121041A1
Human necessities

HEMOSTATIC COMPOSITION CONTAINING RECOMBINANT HUMAN CLOTTING FACTORS, AND METHOD OF PRODUCING

#713
US20250121042A1
Human necessities

LYOPHILIZED FACTOR IX FORMULATIONS

#714
US20250121043A1
Human necessities

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

#715
US20250121044A1
Human necessities

ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

#716
US20250121045A1
Human necessities

DEVELOPMENT OF SYNTHETIC PSEUDAMINIC ACID-BASED ANTIBACTERIAL VACCINES AGAINST ACINETOBACTER BAUMANNII

#717
US20250121046A1
Human necessities

MRNA THERAPEUTIC COMPOSITIONS

#718
US20250121047A1
Human necessities

CHIMERIC VIRUS EXPRESSING PORCINE PRODUCTIVE AND RESPIRATORY SYNDROME VIRUS-DERIVED PEPTIDE AND VACCINE COMPOSITION COMPRISING SAME

#719
US20250121048A1
Human necessities

NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES

#720
US20250121049A1
Human necessities

INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF

#721
US20250121050A1
Human necessities

METHODS OF PRODUCING CELLS RESISTANT TO HIV INFECTION

#722
US20250121051A1
Human necessities

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

#723
US20250121052A1
Human necessities

SARS-COV-2 VACCINES

#724
US20250121053A1
Human necessities

VACCINE COMPOSITIONS AND THEIR USE

#725
US20250121054A1
Human necessities

VACCINES AGAINST CORONAVIRUS AND METHODS OF USE

#726
US20250121055A1
Human necessities

INTERFERON- INDUCING COMPLEXES AND RNA DUPLEXES AND METHODS OF USE

#727
US20250121056A1
Human necessities

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GLP-1 RECEPTOR AGONISTS CONJUGATED TO ANTAGONISTS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)

#728
US20250121057A1
Human necessities

COMBINATION THERAPIES FOR TREATING CANCERS

#729
US20250121058A1
Human necessities

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

#730
US20250121059A1
Human necessities

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#731
US20250121060A1
Human necessities

IMMUNE CELLS WITH ENHANCED EFFICACY

#732
US20250121061A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR INCLUDING CD30-DERIVED INTRACELLULAR SIGNALING DOMAIN, IMMUNE CELL EXPRESSING SAME, AND USE THEREOF

#733 ✅ Patent 12,296,010 granted on 2025-05-13
US20250121062A1
Human necessities

Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy

#734
US20250121063A1
Human necessities

COMPOSITIONS OF LEUKOCYTES WITH RESISTANCE TO PROSTANOIDS AND RELATED METHODS OF USE

#735
US20250121064A1
Human necessities

GPRC5D ANTIBODY AND USE THEREOF

#736
US20250121065A1
Human necessities

INJECTABLE PREPARATION

#737
US20250121066A1
Human necessities

STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE

#738
US20250121067A1
Human necessities

WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME

#739
US20250121068A1
Human necessities

BIFUNCTIONAL MOLECULES AS PROTEASOME STIMULATORS FOR IMPROVED TARGETED PROTEIN DEGRADATION, AND THEIR USES AS TARGETED BOOSTING DEGRADERS (TARBODS)

#740
US20250121069A1
Human necessities

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

#741
US20250121070A1
Human necessities

COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2

#742
US20250121071A1
Human necessities

REAGENTS AND METHODS FOR PREPARING DERIVATIZED RNA MOLECULES AND METHODS OF USE THEREOF

#743
US20250121072A1
Human necessities

COMPOUND COMPRISING SELF-IMMOLATIVE GROUP AND LIGAND-DRUG CONJUGATE COMPRISING SAME

#744
US20250121073A1
Human necessities

IRAK DEGRADERS AND USES THEREOF

#745
US20250121074A1
Human necessities

CNP PRODRUGS WITH CARRIER ATTACHMENT AT THE RING MOIETY

#746
US20250121075A1
Human necessities

ALPHA-FETOPROTEIN BIOCONJUGATES FOR DISEASE TREATMENT

#747
US20250121076A1
Human necessities

POLYPEPTIDE DRUG CONJUGATE HAVING NOVEL STRUCTURE AND APPLICATION THEREOF

#748
US20250121077A1
Human necessities

COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF

#749
US20250121078A1
Human necessities

PEPTIDE DRUG CONJUGATES AND THEIR USES

#750
US20250121079A1
Human necessities

Targeted Protease Compositions and Uses Related Thereto

#751
US20250121080A1
Human necessities

CONJUGATES, THEIR COMPOSITIONS, AND THEIR RELATED METHODS

#752
US20250121081A1
Human necessities

ANTI-ROR1 ANTIBODY, AND ANTI-ROR1 ANTIBODY-DRUG CONJUGATE AND MEDICAL USES THEREOF

#753
US20250121082A1
Human necessities

ANTI-CD228 ANTIBODY AND DRUG CONJUGATE THEREOF

#754
US20250121083A1
Human necessities

Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) Antibody-Maytansine Conjugates and Methods of Use Thereof

#755
US20250121084A1
Human necessities

ANTI-CLAUDIN-6 CONJUGATES

#756
US20250121085A1
Human necessities

ANTIBODY-OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF INDUCING DMD EXON 45 SKIPPING

#757
US20250121086A1
Human necessities

LIVER-TARGETED SUBSTANCE AND USE THEREOF

#758
US20250121087A1
Human necessities

ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-B7-H3 ANTIBODIES

#759
US20250121088A1
Human necessities

ANTI-MUC1* ANTIBODY DRUG COMPLEXES AND USES THEREOF

#760
US20250121089A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING THE EFFECT OF A TROP-2 SPECIFIC THERAPEUTIC

#761
US20250121090A1
Human necessities

Antibody-Drug Conjugates and Methods of Use Thereof

#762
US20250121091A1
Human necessities

PARTICLES WITH COVALENTLY LIPID-BOUND IMMUNOSTIMULATORY AGENTS

#763
US20250121092A1
Human necessities

PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES

#764
US20250121093A1
Human necessities

LENTIVIRAL GENE THERAPY RESCUES FUNCTION IN A MOUSE MODEL OF USHER 1B

#765
US20250121094A1
Human necessities

AAV PARTICLES WITH MODIFIED INVERTED TERMINAL REPEATS FOR ENHANCED GENE EXPRESSION IN MUSCLE

#766
US20250121095A1
Human necessities

RECOMBINANT VIRUS EXPRESSING TPK AND USE THEREOF IN TREATMENT OF ALZHEIMER'S DISEASE

#767
US20250121096A1
Human necessities

ENGINEERED LIVER-SPECIFIC ENHANCERS AND THEIR APPLICATIONS

#768
US20250121097A1
Human necessities

METHODS OF RECOMBINANT ADENO-ASSOCIATED VIRUS KIDNEY ADMINISTRATION

#769
US20250121098A1
Human necessities

BRAIN TARGETED NANOPARTICLES OR CONJUGATES AND METHODS OF USE THEREOF

#770
US20250121099A1
Human necessities

CLOSO-DODECAIODODECABORATE COMPLEXES AND METHODS OF USE FOR SAME

#771
US20250121100A1
Human necessities

COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING

#772
US20250121101A1
Human necessities

METHODS AND DEVICES FOR PREPARATION OF ULTRASOUND CONTRAST AGENTS

#773
US20250121102A1
Human necessities

DUAL MODE RADIOTRACER AND-THERAPEUTICS

#774
US20250121103A1
Human necessities

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

#775
US20250121104A1
Human necessities

EGFR-CMET-TARGETED COMPOUNDS AND USES THEREOF

#776
US20250121105A1
Human necessities

METHODS FOR TREATING CANCER USING COMBINATIONS OF PARP INHIBITORS AND ANTIBODY RADIOCONJUGATES

#777
US20250121106A1
Human necessities

WEARABLE COMPOSITE MATERIALS FOR RAPID IN SITU THERMAL DECONTAMINATION

#778
US20250121107A1
Human necessities

METHOD FOR STEAM STERILIZATION IN AN AUTOCLAVE AND AUTOCLAVE

#779
US20250121108A1
Human necessities

DEVICES, SYSTEMS, AND METHODS FOR STERILIZATION, DISINFECTION, SANITIZATION AND DECONTAMINATION

#780
US20250121109A1
Human necessities

Methods for Organizing the Disinfection of one or More Items Contaminated with Biological Agents

#781
US20250121110A1
Human necessities

Sterilization Indicator Reading Apparatus and Method

#782
US20250121111A1
Human necessities

TECHNIQUES FOR OLFACTORY TRAINING USING SCENT DISPENSING DEVICES

#783
US20250121112A1
Human necessities

SPACE PURIFICATION DEVICE

#784
US20250121113A1
Human necessities

PORTABLE AND FILTER-FREE SINGLE-PASS AIR DISINFECTION SYSTEM FOR DISINFECTION OF CONTAMINATED AIRFLOW OR BIOAEROSOLS

#785
US20250121114A1
Human necessities

MACROPOROUS HYDROXYAPATITE COMPOSITION AND METHODS OF MAKING SUCH

#786
US20250121115A1
Human necessities

PREPARATION METHOD FOR THREE-DIMENSIONAL GELATIN SCAFFOLD WITH INTERCONNECTED PORES AND APPLICATION THEREOF

#787
US20250121116A1
Human necessities

A METHOD FOR MANUFACTURING DENTAL IMPLANTS HAVING HYDROPHILIC SURFACE

#788
US20250121117A1
Human necessities

ADDITIVELY-MANUFACTURED COMPOSITE ROD FOR SPINAL INSTRUMENTATION

#789
US20250121118A1
Human necessities

SYSTEMS, APPARATUSES, KITS, AND METHODS FOR MODIFICATION OF TISSUE USING A PHOTO-INITIATOR AND LIGHT

#790
US20250121119A1
Human necessities

COMPOSITION FOR DEGRADING JOINT BALLOON AND USE THEREOF AS WELL AS DEGRADABLE JOINT BALLOON AND PREPARATION METHOD THEREOF

#791
US20250121120A1
Human necessities

Flushable Disintegration Catheter

#792
US20250121121A1
Human necessities

SUBSTRATES MODIFIED WITH PEPTOID-LOADED MICROGELS FOR RESISTANCE TO BACTERIAL COLONIZATION

#793
US20250121122A1
Human necessities

Blood Treatment Apparatus with Vibration Device

#794
US20250121123A1
Human necessities

Flow Synchronization Devices, Methods, and Systems

#795
US20250121124A1
Human necessities

SURGICAL DRAIN SYSTEM AND METHOD OF USE

#796
US20250121125A1
Human necessities

ADIPOSE TISSUE SEPARATION DEVICE WITH PRESSURE EQUALIZATION

#797
US20250121126A1
Human necessities

ENDOLUMINAL TREATMENT SYSTEMS, DEVICES, AND RELATED METHODS

#798
US20250121127A1
Human necessities

ENDOLUMINAL TREATMENT DEVICES AND RELATED METHODS

#799
US20250121128A1
Human necessities

ANTIMICROBIAL INTRAVENOUS SET

#800
US20250121129A1
Human necessities

LIQUID INFUSION DEVICE EQUIPPED WITH A MAGNETIC RETURN-TO-ORIGIN AND FIXATION MEANS

#801
US20250121130A1
Human necessities

APPARATUS FOR INFUSING MEDICAL LIQUID EQUIPPED WITH A PISTON OPERATION DETECTION SENSOR

#802
US20250121131A1
Human necessities

MEDICAL DEVICE HUB POWER MANAGEMENT SYSTEM, METHOD, AND APPARATUS

#803
US20250121132A1
Human necessities

NEEDLE SYSTEM HAVING CLOSED STATE AND OPEN STATE

#804
US20250121133A1
Human necessities

INSULIN INFUSION SET

#805
US20250121134A1
Human necessities

Hemodynamic Sensor Systems for Predicting and Diagnosing Endotypes of Hypotension

#806
US20250121135A1
Human necessities

AUTO-INJECTION MEDICAL DEVICE SYSTEM

#807
US20250121136A1
Human necessities

METHOD AND DEVICE FOR DELIVERING A SUBCUTANEOUS DOSE THROUGH MULTIPLE INJECTIONS

#808
US20250121137A1
Human necessities

RESHAPING OF INJECTOR DEVICE STOPPER FEATURES

#809
US20250121138A1
Human necessities

SYRINGE CAPABLE OF REMOVING RESIDUAL PRESSURE

#810
US20250121139A1
Human necessities

DRUG DELIVERY DEVICE FOR LIQUID PHARMACEUTICALS

#811
US20250121140A1
Human necessities

OPTICAL CONFIGURATION OF A MEDICAMENT RESERVOIR OF A DRUG DELIVERY DEVICE

#812
US20250121141A1
Human necessities

Flexible Modules for Injection Devices

#813
US20250121142A1
Human necessities

RETRACTION MECHANISM FOR SAFE INJECTION SYSTEM

#814
US20250121143A1
Human necessities

Universal Atomizer

#815
US20250121144A1
Human necessities

VORTEX TUBE ASSEMBLY AND BREATHING DEVICE

#816
US20250121145A1
Human necessities

ARRANGEMENT AND PROCESS FOR MEASURING THE RESPECTIVE CONCENTRATION OF THREE GAS COMPONENTS IN A GAS SAMPLE

#817
US20250121146A1
Human necessities

DISPLAY OF A PRE-SET STARTING DOSE OF NO ON A MEDICAL GAS SUPPLY APPARATUS

#818
US20250121147A1
Human necessities

ADJUSTABLE SECUREMENT DEVICE FOR ENDOTRACHEAL TUBE

#819
US20250121148A1
Human necessities

ORAL AND NASAL SEALING INTERFACE PAD

#820
US20250121149A1
Human necessities

PATIENT INTERFACE HAVING SEAL-FORMING STRUCTURE WITH VARYING CONSTRUCTION

#821
US20250121150A1
Human necessities

PRESSURIZING MASKS, SYSTEMS AND METHODS

#822
US20250121151A1
Human necessities

HIGH FLOW OXYGEN THERAPY BREATHING SYSTEMS

#823
US20250121152A1
Human necessities

NASAL TUBE DEVICES FOR SECURING A NASAL TUBE AND ONE OR MORE OTHER TUBES TO A NOSE OF A PATIENT

#824
US20250121153A1
Human necessities

NO DELIVERY APPARATUS COMPRISING AN ANALYSIS LINE WITH PIEZOELECTRIC PUMP

#825
US20250121154A1
Human necessities

BED DEVICE SYSTEM AND METHODS

#826
US20250121155A1
Human necessities

SYSTEM FOR PROVIDING COGNITIVE FUNCTION ENHANCEMENT SERVICE USING ARTIFICIAL INTELLIGENCE-BASED BRAINWAVE ENTRAINMENT AND LIGHT THERAPY

#827
US20250121156A1
Human necessities

COMPOSITE MEDICAL BALLOON WITH ENHANCED OUTER FILM LAYER AND RELATED METHODS

#828
US20250121157A1
Human necessities

MEDICAL TUBE CLEARANCE DEVICE

#829
US20250121158A1
Human necessities

ATRAUMATIC CATHETER

#830
US20250121159A1
Human necessities

Guidewire-Management Devices and Methods Thereof

#831
US20250121160A1
Human necessities

ACTIVE DISTAL TIP DRIVE

#832
US20250121161A1
Human necessities

EXPANDABLE SHEATH WITH TRAPPING DILATOR

#833
US20250121162A1
Human necessities

EXPANDABLE SHEATH WITH TRAPPING DILATOR

#834
US20250121163A1
Human necessities

STEERABLE GUIDING SHEATH WITH RACK AND PINION DEFLECTION MECHANISM

#835
US20250121164A1
Human necessities

MULTI-DUROMETER POLYMER EXTRUSIONS FOR SMOOTH STIFFNESS TRANSITION IN INTRALUMINAL GUIDEWIRES AND/OR CATHETERS

#836
US20250121165A1
Human necessities

Guidewire-Management Devices and Methods Thereof

#837
US20250121166A1
Human necessities

DEVICES, SYSTEMS AND METHODS FOR SKIN TREATMENT

#838
US20250121167A1
Human necessities

Microneedle Device and Method for Detecting At Least One Force Acting on a Microneedle Array

#839
US20250121168A1
Human necessities

HIGH-PERFORMANCE MICRONEEDLE ARRAY

#840
US20250121169A1
Human necessities

DISSOLVABLE MICRONEEDLES FOR SKIN TEATMENT

#841
US20250121170A1
Human necessities

APPLICATOR FOR IMPLANT INSERTION

#842
US20250121171A1
Human necessities

PORT LOCATOR FOR AN IMPLANT

#843
US20250121172A1
Human necessities

TUBING HAVING VISUAL MARKERS FOR VISUALIZATION OF MEDIA THEREIN

#844
US20250121173A1
Human necessities

DEVICE AND METHOD FOR REDUCING BLOCKAGE IN TUBING SYSTEMS

#845
US20250121174A1
Human necessities

DEVICE FOR DELIVERY OF ANTIMICROBIAL AGENT INTO A MEDICAL DEVICE

#846
US20250121175A1
Human necessities

DISTAL EXTENSION FOR BLOOD PUMP SYSTEMS

#847
US20250121176A1
Human necessities

CATHETER DEVICE HAVING A COUPLING DEVICE FOR A DRIVE DEVICE

#848
US20250121177A1
Human necessities

INTRACARDIAC BLOOD PUMP WITH CAPACITIVE SENSING LOCATION DETECTION

#849
US20250121178A1
Human necessities

Implanted Connector Booster Sealing for Implantable Medical Devices

#850
US20250121179A1
Human necessities

HEART PUMP ASSEMBLY WITH A PUMP HOUSING CONFIGURED TO REDUCE HEMOLYSIS

#851
US20250121180A1
Human necessities

SYSTEM FOR ELECTRICAL STIMULATION

#852
US20250121181A1
Human necessities

Honeycomb-shaped electro-neural interface for retinal prosthesis

#853
US20250121182A1
Human necessities

ELECTRODE LEADS HAVING MULTI-APPLICATION NERVE CUFFS AND ASSOCIATED SYSTEMS AND METHODS

#854
US20250121183A1
Human necessities

HAND PIECE FOR SKIN TREATMENT APPARATUS

#855
US20250121184A1
Human necessities

Load Supporting Implant

#856
US20250121185A1
Human necessities

ALTERNATING ELECTRODES BETWEEN MEASUREMENT AND INTERVENTION MODES TO ADDRESS HYPEREXCITABILITY

#857
US20250121186A1
Human necessities

INTERLEAVED STIMULATION FOR MOTOR CONTROL

#858
US20250121187A1
Human necessities

MONOTONIC AMPLITUDE PULSE TRAINS FOR NON-INVASIVE NEUROSTIMULATION

#859
US20250121188A1
Human necessities

CONTROL OF VAGAL STIMULATION

#860
US20250121189A1
Human necessities

VENTRAL SPINAL CORD STIMULATION FOR AT LEAST PARTIAL RESTORATION OF MOTOR FUNCTION

#861
US20250121190A1
Human necessities

CONFIGURING A DEEP BRAIN STIMULATION (DBS) SYSTEM TO TREAT A NEUROLOGICAL DISORDER

#862 ✅ Patent 12,285,612 granted on 2025-04-29
US20250121191A1
Human necessities

Systems and methods for restoring muscle function to the lumbar spine

#863
US20250121192A1
Human necessities

SYSTEMS AND METHODS FOR THE TREATMENT OF PAIN THROUGH NEURAL FIBER STIMULATION

#864
US20250121193A1
Human necessities

SYSTEMS AND METHODS FOR MODULATING BRAIN ACTIVITY

#865
US20250121194A1
Human necessities

APPARATUS AND METHODS FOR ASSISTED BREATHING BY TRANSVASCULAR NERVE STIMULATION

#866
US20250121195A1
Human necessities

Neural Sensing in an Implantable Stimulator Device During Passive Charge Recovery

#867
US20250121196A1
Human necessities

EVOKED RESPONSE-GUIDED MULTISITE DEEP BRAIN STIMULATION

#868
US20250121197A1
Human necessities

SYSTEMS AND METHODS FOR TREATMENT OF DRY EYE

#869
US20250121198A1
Human necessities

STIMULATION CYCLING ADJUSTMENTS BASED ON USER INPUT

#870
US20250121199A1
Human necessities

AUTOMATING DATA DOWNLOAD IN A SYSTEM REQUIRING RESPONSIVENESS TO A SECONDARY CONTROL UNIT

#871
US20250121200A1
Human necessities

HERMETIC CONNECTOR STACKS FOR AN ELECTRICAL STIMULATION SYSTEM

#872
US20250121201A1
Human necessities

SYSTEMS AND METHODS TO ENHANCE MEMORY USING NON-INVASIVE BRAIN STIMULATION

#873
US20250121202A1
Human necessities

APPARATUS FOR NEURAL STIMULATION AND METHOD OF USE

#874
US20250121203A1
Human necessities

ENHANCING EPITHELIAL INTEGRITY BY A SEQUENCE OF MAGNETIC PULSES

#875
US20250121204A1
Human necessities

PORTABLE PULSED ELECTROMAGNETIC FIELD GENERATOR

#876
US20250121205A1
Human necessities

SYSTEMS AND METHODS OF TREATING MEDICAL INDICATIONS BY ADMINISTERING DOSAGES OF LIGHT AND SOUND

#877
US20250121206A1
Human necessities

Wearable Light Therapy Device

#878
US20250121207A1
Human necessities

HEAD OPTICAL APPLICATION DEVICE, TRANSCRANIAL LIGHT REGULATION DEVICE AND NEAR INFRARED DEVICE

#879
US20250121208A1
Human necessities

RADIOTHERAPY TREATMENT PLAN EVALUATION AND IMPROVEMENT

#880
US20250121209A1
Human necessities

METHOD FOR MODIFYING MEDICAL IMAGING PROTOCOL PARAMETERS

#881
US20250121210A1
Human necessities

Bore based medical system comprising a camera carrier configured to be mounted in the bore-based medical systems and utilized for positioning and monitoring of patients during radiotherapy treatment

#882
US20250121211A1
Human necessities

SYSTEMS AND METHODS FOR USE IN EMISSION GUIDED RADIATION THERAPY

#883
US20250121212A1
Human necessities

METHOD TO SYNTHESIZE ALGINATE-BASED POROUS HYDROGEL MATERIAL WITH MECHANICAL AND RADIOLOGICAL PROPERTIES EQUIVALENT TO HUMAN ORGAN

#884
US20250121213A1
Human necessities

DEVICES AND TECHNIQUES FOR ULTRASOUND THERAPY VIA A DIALYSIS SYSTEM

#885
US20250121214A1
Human necessities

INCOHERENT FIELD SONODYNAMIC THERAPY FOR TREATING CANCER

#886
US20250121215A1
Human necessities

TFUS SYSTEM CONFIGURED WITH SIMPLIFIED PROBES

#887
US20250121216A1
Human necessities

SYSTEMS AND METHODS FOR RELIABLE REPLACEMENT OF ULTRASOUND NEUROMODULATION WEARABLES

#888
US20250121217A1
Human necessities

METHODS OF TREATING CANCER WITH DRUGS

#889
US20250121218A1
Human necessities

APPARATUS AND METHOD FOR ULTRASOUND SPINAL CORD STIMULATION

#890
US20250121219A1
Human necessities

NON-IMAGING TFUS SYSTEMS

#891
US20250121220A1
Human necessities

BETACORONAVIRUS mRNA VACCINES

#892
US20250121221A1
Human necessities

BETACORONA VIRUS mRNA VACCINES

#893
US20250121222A1
Human necessities

TOPICAL SKIN FORMULATIONS

#894
US20250121223A1
Human necessities

Fire Detection and Warning Systems, Devices, and Methods for Kitchen Ventilation

#895
US20250121224A1
Human necessities

METHOD AND A SYSTEM FOR PROVIDING FIRE SAFETY OF A CAR PARK

#896
US20250121225A1
Human necessities

UPPER COVER FOR BATTERY SYSTEM ASSEMBLY

#897
US20250121226A1
Human necessities

SYSTEM AND METHOD FOR VERIFYING OPERATIONAL INTEGRITY OF A SPRINKLER HEAD

#898
US20250121227A1
Human necessities

ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS FORMULATED USING ALKALI METAL SALTS OF FORMIC ACID FOR PROTECTING PROPERTY AGAINST WILDFIRE

#899
US20250121228A1
Human necessities

ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS FORMULATED USING ALKALI METAL SALTS OF CARBONIC ACID FOR PROTECTING PROPERTY AGAINST WILDFIRE

#900
US20250121229A1
Human necessities

ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS FORMULATED USING ALKALI METAL SALTS OF ACETIC ACID FOR PROTECTING PROPERTY AGAINST WILDFIRE